Innoviva (INVA) FCF Payout Ratio Growth (3y) (2017 - 2022)
Powered by 
Analysis
Innoviva (INVA) FCF Payout Ratio Growth (3y) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.12% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 25.39% |
| Jun 30, 2022 | 1,215.24% |
| Mar 31, 2022 | 759.80% |
| Sep 30, 2021 | 74.12% |
| Jun 30, 2021 | 147.90% |
| Mar 31, 2021 | 419.69% |
| Dec 31, 2020 | 118.58% |
| Jun 30, 2020 | 341.73% |
| Mar 31, 2020 | 346.75% |
| Sep 30, 2019 | 313.00% |
| Jun 30, 2019 | -82.53% |
| Mar 31, 2019 | -89.83% |
| Dec 31, 2018 | 22.45% |
| Sep 30, 2018 | -85.55% |
| Jun 30, 2018 | -89.49% |
| Mar 31, 2018 | 25.99% |
| Jun 30, 2017 | 26.00% |